Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 24;89(1):37-47.
eCollection 2016 Mar.

Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology

Josip Anđelo Borovac  1
Affiliations
Review

Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology

Josip Anđelo Borovac. Yale J Biol Med. .

Abstract

Dopamine agonists (DA) are therapeutic agents that are commonly used in the treatment of Parkinson's disease (PD). They can reduce undesired motor fluctuations and delay the administration of levodopa therapy. However, this drug family is associated with specific side effects that can significantly diminish the quality of life among PD patients. Some of them impose significant risks for individuals who have a history of cardiovascular diseases, psychosis, and depression, or those older patients who suffer from renal or hepatic insufficiency. Various pharmacokinetic and pharmacodynamic considerations need to be taken into account when administering DA therapy. The goal of this review is to provide a comprehensive, up-to-date overview of DA therapeutic modalities for PD.

Keywords: Parkinson’s disease; adverse effects; clinical; dopamine; dopamine agonists; patient safety; pharmacology; side effects.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kvernmo T, Hartter S, Burger E. A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clin Ther. 2006;8(28):1065–1078. - PubMed
    1. Pignatelli M, Bonci A. Role of Dopamine Neurons in Reward and Aversion: A Synaptic Plasticity Perspective. Neuron. 2015;5(86):1145–1157. - PubMed
    1. Beninger RJ. The role of dopamine in locomotor activity and learning. Brain Res. 1983;287(2):173–196. - PubMed
    1. Iversen SD, Iversen L. Dopamine: 50 years in perspective. Trends Neurosci. 2007;30(5):188–193. - PubMed
    1. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine Receptors: From Structure to Function. Physiol Rev. 1998;78(1):189–225. - PubMed

Substances